This study aims to compare two FDA approved medications (aripiprazole and risperidone) for the treatment of behavioral dysregulation in children with autism spectrum disorders. This trial, done in the context of routine clinical care, will seek to evaluate whether aripiprazole or risperidone is associated with more weight gain in children.
Weight Gain, Autism Spectrum Disorder, Medication Side Effect
This study aims to compare two FDA approved medications (aripiprazole and risperidone) for the treatment of behavioral dysregulation in children with autism spectrum disorders. This trial, done in the context of routine clinical care, will seek to evaluate whether aripiprazole or risperidone is associated with more weight gain in children.
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
-
Division of Developmental Medicine, Nashville, Tennessee, United States, 37212
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to 17 Years
ALL
Yes
Vanderbilt University Medical Center,
Angela Maxwell-Horn, M.D., PRINCIPAL_INVESTIGATOR, Vanderbilt University Medical Center
2025-07-01